drugset / Trial / NCT02162381

Methylphenidate Effect on Humphrey Visual Fields

NCT02162381 ↗

Completed 32 enrolled Rabin Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

Study will include adults with abnormal visual fields. Half of them will be given either methylphenidate 10mg 2 hours before repeating the visual field test. the rest will serve as controls. All Subjects will also have a complete eye examination, a short questionnaire and a questionnaire to screen for attention deficit disorder. The investigators will compare the visual field results between the 2 tests.

Timeline

Start
2014-06
Primary completion
2018-04-10
Completion
2018-04-10

Outcome

Mixed primary results

paper Mean deviation improved by median 68% (IQR 19%-78%) in the methylphenidate group vs. 27% [-5% to 55%] in the controls. PMID 33342320 ↗

paper However, this was not statistically significant (p = .83). PMID 33342320 ↗

paper Pattern standard deviation improved by median 49% (22%-59%) vs. 7% [-9% to 45%], respectively (p = .012). PMID 33342320 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 10 mg Oral

Indications

No indication recorded.